Watch On-Demand. Recorded December 2009.
How has increased scrutiny from payers impacted the way pharmaceutical companies bring products to market? What role does the challenging FDA approval environment play in commercialization strategies? Find out the answers to these questions and more in this webisode.
Bob Mauch, President of Xcenda discusses how payers have forced a change in Pharma's approach to launching and commercializing products. Learn how Pharma companies can address changes in product value messaging, interactions among Pharma and payers, as well as potential game-changers like comparative effectiveness to drive product success.
Specifically, we will explore:
This webisode is part of “In the Know,” a twice-monthly dose of thought leadership developed by AmerisourceBergen Specialty Group. "In the Know" uses a rapid-fire, Q&A format to deliver the insights that matter most -- all in less than 15 minutes per webisode. Learn more and view other webisodes at knowledgedriven.com.